Microarray analysis also revealed an upregulation in ALDH1A3 and NR4A3, which are genes that have since been identified as being commonly recognized biomarkers for carcinoma-associated fibroblasts (CAFs) in skin disorders including basal cell carcinoma and systemic sclerosis [44–47]. This evidence concerns the gene NR4A3 and basal cell carcinoma.